| Oct 16 |
Organogenesis Holdings Inc. to Report Third Quarter of Fiscal Year 2024 Financial Results on November 12, 2024
|
| Oct 15 |
Organogenesis: Lurking Disruption With Recovery To Follow
|
| Oct 1 |
Organogenesis Announces Publication of Randomized Clinical Trial Results Demonstrating the Safety and Efficacy of NuShield for Diabetic Foot Ulcers
|
| Sep 4 |
Organogenesis Holdings Inc. to Participate in Upcoming Investor Conferences in September
|
| Aug 10 |
Organogenesis Holdings Second Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
|
| Jul 20 |
Organogenesis Holdings Inc. (ORGO): Is It Among the Best NASDAQ Penny Stocks to Invest In Now?
|
| Jul 15 |
Organogenesis Holdings Inc. to Report Second Quarter of Fiscal Year 2024 Financial Results on August 8, 2024
|
| Jul 5 |
Organogenesis Holdings Inc.'s (NASDAQ:ORGO) Stock Is Going Strong: Have Financials A Role To Play?
|
| Jun 10 |
Organogenesis Holdings: Small-Cap Biotech With Inconsistent Earnings And A Powerful Catalyst
|
| May 12 |
Organogenesis Holdings First Quarter 2024 Earnings: Beats Expectations
|
